| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 1, 2006
From the the National Institute of Neurological Disorders and Stroke, National Institutes of Health (M.L., J.L.B., J.G.M., S.W.), Bethesda, Maryland; and Neurologische Klinik, Universitätsklinikum Erlangen (P.D.S.), Erlangen, Germany. * To whom correspondence should be addressed. E-mail: lubym{at}ninds.nih.gov.
Background and Purpose--We investigated the intra- and interrater reliability of ischemic lesion volumes measurements assessed by different MRI sequences at various times from onset. Methods--Ischemic lesion volumes were measured for intrarater reliability using diffusion-weighted (DWI), mean transit time (MTT) perfusion and fluid-attenuated inversion recovery (FLAIR) MRI at chronic (>3 days from stroke onset) time points. A single intrarater reader, blind to clinical information and time point, repeated the volume measurements on two occasions separated by at least 1 week. Interrater reliability was also obtained in the second set of patients using acute DWI, MTT and chronic FLAIR MRI. Four blinded readers performed these volume measurements. Average deviations across repeat measurements per lesion and differences between sample means between the two measurements were calculated globally, ie, across all sequences and time points, and per reader type for each sequence at each time point. Results--There was good concordance of the mean sample volumes of the 2 intrarater readings (deviations were <4% and 2 mL globally, <2% and 2 mL for DWI, <6% and 7 mL for MTT, and <2% and 1 mL for FLAIR). There was also good concordance of the interrater readings (<5% and 2 mL globally). Conclusions--Repeat measurements of stroke lesion volumes show excellent intra- and interrater concordance for DWI, MTT and FLAIR at acute through chronic time points.
Revised on August 3, 2006
Accepted on August 15, 2006
Intra- and Interrater Reliability of Ischemic Lesion Volume Measurements on Diffusion-Weighted, Mean Transit Time and Fluid-Attenuated Inversion Recovery MRI
Marie Luby MEng, MS*;
This article has been cited by other articles:
![]() |
K. M. Barrett, Y. H. Ding, D. P. Wagner, D. F. Kallmes, K. C. Johnston, and for the ASAP Investigators Change in Diffusion-Weighted Imaging Infarct Volume Predicts Neurologic Outcome at 90 Days: Results of the Acute Stroke Accurate Prediction (ASAP) Trial Serial Imaging Substudy Stroke, July 1, 2009; 40(7): 2422 - 2427. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.G. Kranz and J.D. Eastwood Does Diffusion-Weighted Imaging Represent the Ischemic Core? An Evidence-Based Systematic Review AJNR Am. J. Neuroradiol., June 1, 2009; 30(6): 1206 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ebinger, S. Christensen, D. A. De Silva, M. W. Parsons, C. R. Levi, K. S. Butcher, C. F. Bladin, P. A. Barber, G. A. Donnan, S. M. Davis, et al. Expediting MRI-Based Proof-of-Concept Stroke Trials Using an Earlier Imaging End Point Stroke, April 1, 2009; 40(4): 1353 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Gaudinski, E. C. Henning, A. Miracle, M. Luby, S. Warach, and L. L. Latour Establishing Final Infarct Volume: Stroke Lesion Evolution Past 30 Days Is Insignificant Stroke, October 1, 2008; 39(10): 2765 - 2768. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Schellinger and J. B. Fiebach Establishing Final Infarct Volume: Stroke Lesion Evolution Past 30 Days Is Insignificant Stroke, October 1, 2008; 39(10): 2693 - 2694. [Full Text] [PDF] |
||||
![]() |
S. B. Coutts, M. D. Hill, C. R. Campos, Y. B. Choi, S. Subramaniam, J. C. Kosior, A. M. Demchuk, and for the VISION study group Recurrent Events in Transient Ischemic Attack and Minor Stroke: What Events Are Happening and to Which Patients? Stroke, September 1, 2008; 39(9): 2461 - 2466. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ay, E. M. Arsava, M. Vangel, B. Oner, M. Zhu, O. Wu, A. Singhal, W. J. Koroshetz, and A. G. Sorensen Interexaminer Difference in Infarct Volume Measurements on MRI: A Source of Variance in Stroke Research Stroke, April 1, 2008; 39(4): 1171 - 1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Butcher, M. Parsons, L. Allport, S. B. Lee, P. A. Barber, B. Tress, G. A. Donnan, S. M. Davis, and for the EPITHET Investigators Rapid Assessment of Perfusion-Diffusion Mismatch Stroke, January 1, 2008; 39(1): 75 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Merino, L. L. Latour, J. W. Todd, M. Luby, P. D. Schellinger, D.-W. Kang, and S. Warach Lesion Volume Change After Treatment With Tissue Plasminogen Activator Can Discriminate Clinical Responders From Nonresponders Stroke, November 1, 2007; 38(11): 2919 - 2923. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |